Loading…
Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture
The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with...
Saved in:
Published in: | Glycobiology (Oxford) 2002-05, Vol.12 (5), p.345-351 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3 |
container_end_page | 351 |
container_issue | 5 |
container_start_page | 345 |
container_title | Glycobiology (Oxford) |
container_volume | 12 |
creator | Yabushita, Hiromitsu Noguchi, Yasuyuki Habuchi, Hiroko Ashikari, Satoko Nakabe, Ken Fujita, Masaru Noguchi, Masayoshi Esko, Jeffrey D. Kimata, Koji |
description | The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection. |
doi_str_mv | 10.1093/glycob/12.5.345 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71832019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71832019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</originalsourceid><addsrcrecordid>eNqF0c2LEzEYBvAgiltXz94kePA2bd5kkkyPUldXKMjCiuIlZDJvbHZnJjWZke1_b0qLgpc95fD-8uTjIeQ1sCWwtVj97A8utivgS7kUtXxCFlArVvGai6dkwdZyXSklmwvyIuc7xkBBI5-TC-BMM6b1guQr79FNmUZP3Q6H4GzfH-gQu-ADdnSHe5vCSONIN7veDocuWDol63ZxsFPINGOKv22iW07DeIwKhZYwnO9tOsQpOOqw73OZUjf305zwJXnmbZ_x1Xm9JF8_Xt1urqvtl0-fN--3lasFmyrhHdbgUHVd3anWKtUooZnSHUeH3mvvFbMeZCMcCg2ubaUV6DXnYJVHcUnenXL3Kf6aMU9mCPl4GTtinLPR0AjOYP0o5Kyuy-miwLf_wbs4p7E8wnBggkHDoKDVCbkUc07ozT6FoXyGAWaOrZlTawa4kaa0Vna8OcfO7YDdP3-uqYDqBEKe8OHv3KZ7o7TQ0lx__2FuPvBvaivBSPEHKFulLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210301801</pqid></control><display><type>article</type><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><source>Oxford Journals Online</source><creator>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</creator><creatorcontrib>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</creatorcontrib><description>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</description><identifier>ISSN: 0959-6658</identifier><identifier>EISSN: 1460-2423</identifier><identifier>DOI: 10.1093/glycob/12.5.345</identifier><identifier>PMID: 12070077</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Chlamydia trachomatis ; Chlamydia trachomatis - drug effects ; Chlamydia trachomatis - pathogenicity ; CHO Cells ; Cricetinae ; HeLa Cells ; Heparan Sulfate Proteoglycans - physiology ; Heparin - pharmacology ; Heparin Lyase - pharmacology ; Humans ; Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</subject><ispartof>Glycobiology (Oxford), 2002-05, Vol.12 (5), p.345-351</ispartof><rights>Copyright Oxford University Press(England) May 1, 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</citedby><cites>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12070077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yabushita, Hiromitsu</creatorcontrib><creatorcontrib>Noguchi, Yasuyuki</creatorcontrib><creatorcontrib>Habuchi, Hiroko</creatorcontrib><creatorcontrib>Ashikari, Satoko</creatorcontrib><creatorcontrib>Nakabe, Ken</creatorcontrib><creatorcontrib>Fujita, Masaru</creatorcontrib><creatorcontrib>Noguchi, Masayoshi</creatorcontrib><creatorcontrib>Esko, Jeffrey D.</creatorcontrib><creatorcontrib>Kimata, Koji</creatorcontrib><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><title>Glycobiology (Oxford)</title><addtitle>Glycobiology</addtitle><description>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</description><subject>Animals</subject><subject>Chlamydia trachomatis</subject><subject>Chlamydia trachomatis - drug effects</subject><subject>Chlamydia trachomatis - pathogenicity</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>HeLa Cells</subject><subject>Heparan Sulfate Proteoglycans - physiology</subject><subject>Heparin - pharmacology</subject><subject>Heparin Lyase - pharmacology</subject><subject>Humans</subject><subject>Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</subject><issn>0959-6658</issn><issn>1460-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqF0c2LEzEYBvAgiltXz94kePA2bd5kkkyPUldXKMjCiuIlZDJvbHZnJjWZke1_b0qLgpc95fD-8uTjIeQ1sCWwtVj97A8utivgS7kUtXxCFlArVvGai6dkwdZyXSklmwvyIuc7xkBBI5-TC-BMM6b1guQr79FNmUZP3Q6H4GzfH-gQu-ADdnSHe5vCSONIN7veDocuWDol63ZxsFPINGOKv22iW07DeIwKhZYwnO9tOsQpOOqw73OZUjf305zwJXnmbZ_x1Xm9JF8_Xt1urqvtl0-fN--3lasFmyrhHdbgUHVd3anWKtUooZnSHUeH3mvvFbMeZCMcCg2ubaUV6DXnYJVHcUnenXL3Kf6aMU9mCPl4GTtinLPR0AjOYP0o5Kyuy-miwLf_wbs4p7E8wnBggkHDoKDVCbkUc07ozT6FoXyGAWaOrZlTawa4kaa0Vna8OcfO7YDdP3-uqYDqBEKe8OHv3KZ7o7TQ0lx__2FuPvBvaivBSPEHKFulLA</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>Yabushita, Hiromitsu</creator><creator>Noguchi, Yasuyuki</creator><creator>Habuchi, Hiroko</creator><creator>Ashikari, Satoko</creator><creator>Nakabe, Ken</creator><creator>Fujita, Masaru</creator><creator>Noguchi, Masayoshi</creator><creator>Esko, Jeffrey D.</creator><creator>Kimata, Koji</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20020501</creationdate><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><author>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Chlamydia trachomatis</topic><topic>Chlamydia trachomatis - drug effects</topic><topic>Chlamydia trachomatis - pathogenicity</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>HeLa Cells</topic><topic>Heparan Sulfate Proteoglycans - physiology</topic><topic>Heparin - pharmacology</topic><topic>Heparin Lyase - pharmacology</topic><topic>Humans</topic><topic>Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yabushita, Hiromitsu</creatorcontrib><creatorcontrib>Noguchi, Yasuyuki</creatorcontrib><creatorcontrib>Habuchi, Hiroko</creatorcontrib><creatorcontrib>Ashikari, Satoko</creatorcontrib><creatorcontrib>Nakabe, Ken</creatorcontrib><creatorcontrib>Fujita, Masaru</creatorcontrib><creatorcontrib>Noguchi, Masayoshi</creatorcontrib><creatorcontrib>Esko, Jeffrey D.</creatorcontrib><creatorcontrib>Kimata, Koji</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Glycobiology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yabushita, Hiromitsu</au><au>Noguchi, Yasuyuki</au><au>Habuchi, Hiroko</au><au>Ashikari, Satoko</au><au>Nakabe, Ken</au><au>Fujita, Masaru</au><au>Noguchi, Masayoshi</au><au>Esko, Jeffrey D.</au><au>Kimata, Koji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</atitle><jtitle>Glycobiology (Oxford)</jtitle><addtitle>Glycobiology</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>12</volume><issue>5</issue><spage>345</spage><epage>351</epage><pages>345-351</pages><issn>0959-6658</issn><eissn>1460-2423</eissn><abstract>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>12070077</pmid><doi>10.1093/glycob/12.5.345</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-6658 |
ispartof | Glycobiology (Oxford), 2002-05, Vol.12 (5), p.345-351 |
issn | 0959-6658 1460-2423 |
language | eng |
recordid | cdi_proquest_miscellaneous_71832019 |
source | Oxford Journals Online |
subjects | Animals Chlamydia trachomatis Chlamydia trachomatis - drug effects Chlamydia trachomatis - pathogenicity CHO Cells Cricetinae HeLa Cells Heparan Sulfate Proteoglycans - physiology Heparin - pharmacology Heparin Lyase - pharmacology Humans Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans |
title | Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A27%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chemically%20modified%20heparin%20on%20Chlamydia%20trachomatis%20serovar%20L2%20infection%20of%20eukaryotic%20cells%20in%20culture&rft.jtitle=Glycobiology%20(Oxford)&rft.au=Yabushita,%20Hiromitsu&rft.date=2002-05-01&rft.volume=12&rft.issue=5&rft.spage=345&rft.epage=351&rft.pages=345-351&rft.issn=0959-6658&rft.eissn=1460-2423&rft_id=info:doi/10.1093/glycob/12.5.345&rft_dat=%3Cproquest_cross%3E71832019%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=210301801&rft_id=info:pmid/12070077&rfr_iscdi=true |